CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Open-market buy CEO bought 25,000 shares at $0.18 ($4,550)
- 4 Open-market buy CEO bought 25,000 shares at $0.18 ($4,538)
- 4 Open-market buy CFO, Pres.,Sec., Vice Chairman bought 79,104 shares at an average $0.18 ($14,240)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO bought 100,000 shares at $0.24 ($24,200)
- 4 Open-market buy CFO, Vice Chairman, Secretary bought 100,000 shares at $0.24 ($24,430)
- 4 Open-market buy CEO bought 100,000 shares at $0.24 ($24,000)
- 4 Open-market buy CFO, Vice Chairman, Secretary bought 100,000 shares at $0.24 ($23,910)
- 4 Open-market buy CEO bought 73,681 shares at $0.23 ($16,947)
- 4 Open-market buy CEO bought 26,319 shares at $0.23 ($6,053)
- 4 Open-market buy CFO, Vice Chairman, Secretary bought 100,000 shares at $0.23 ($22,540)
- 4 Gift Director gave 50,663 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 20 of 31 · 616 filings